Retraction: miR‑218 inhibits the migration and invasion of glioma U87 cells through the Slit2‑Robo1 pathway (Oncol Lett 2015 9 (1561-1566) DOI: 10.3892/ol.2015.2904);MiR-218 inhibits the migration and invasion of glioma u87 cells through the slit2-robo1 pathway

Oncology Letters

Volumn 9, Issue 4, 2015, Pages 1561-1566

  Gu, Jian Jun ^a   Gao, Guang Zhong ^a   Zhang, Shi Ming ^b  

^a TAIZHOU PEOPLE S HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Gliomas; Invasiveness; MiR 218; Robo1; Slit2

Indexed keywords

MICRORNA; MICRORNA 218; ROUNDABOUT RECEPTOR; ROUNDABOUT RECEPTOR 1; SLIT2 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; LUCIFERASE ASSAY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR INVASION; WESTERN BLOTTING;

EID: 84923172047     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2023.14068     Document Type: Erratum

References (27)

1. Dallol A, Krex D, Hesson L, Eng C, Maher ER and Latif F: Frequent epigenetic inactivation of the SLIT2 gene in gliomas. Oncogene 22: 4611-4616, 2003.
2. Louis DN, Ohgaki H, Wiestler OD, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109, 2007.
3. Grauer OM, Wesseling P and Adema GJ: Immunotherapy of diffuse gliomas: biological background, current status and future development. Brain Pathol 19: 674-693, 2009.
4. Dontula R, Dinasarapu A, Chetty C, et al: MicroRNA 203 Modulates Glioma Cell Migration via Robo1/ERK/MMP-9 Signaling. Genes Cancer 4: 285-296, 2013.
5. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
6. Long JM and Lahiri DK: Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders. Exp Neurol 235: 402-418, 2012.
7. Park S and James CD: ECop (EGFR-coamplified and overexpressed protein), a novel protein, regulates NF-kappaB transcriptional activity and associated apoptotic response in an IkappaBalpha-dependent manner. Oncogene 24: 2495-2502, 2005.
8. Xu B, Hsu PK, Karayiorgou M and Gogos JA: MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction. Neurobiol Dis 46: 291-301, 2012.
9. Godlewski J, Nowicki MO, Bronisz A, Williams S, et al: Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68: 9125-9130, 2008.
10. Silber J, Lim DA, Petritsch C, et al: MiR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6: 14, 2008.
11. Rao SA, Santosh V and Somasundaram K: Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol 23: 1404-1417, 2010.
12. Song L, Huang Q, Chen K, et al: MiR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β. Biochem Biophys Res Commun 402: 135-140, 2010.
13. Xia H, Yan Y, Hu M, et al: MiR-218 sensitizes glioma cells to apoptosis and inhibits tumorigenicity by regulating ECOP-mediated suppression of NF-κB activity. Neuro Oncol 15: 413-422, 2013.
14. Liu Y, Yan W, Zhang W, et al: MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1. Oncol Rep 28: 1013-1021, 2012.
15. Zhang JM, Sun CY, Yu SZ, et al: Relationship between miR-218 and CDK6 expression and their biological impact on glioma cell proliferation and apoptosis. Zhonghua Bing Li Xue Za Zhi 40: 454-459, 2011 (In Chinese).
16. Tie J, Pan Y, Zhao L, et al: MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 6: e1000879, 2010.
17. Alajez NM, Lenarduzzi M, Ito E, et al: MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res 71: 2381-2391, 2011.
18. Stupp R, Mason WP, van den Bent MJ, et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005.
19. Furnari FB, Fenton T, Bachoo RM, et al: Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21: 2683-2710, 2007.
20. Yiin JJ, Hu B, Jarzynka MJ, et al: Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity. Neuro Oncol 11: 779-789, 2009.
21. Martinez I, Gardiner AS, Board KF et al: Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27: 2575-2582, 2008.
22. Petrocca F, Visone R, Onelli MR, et al: E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosisin gastric cancer. Cancer Cell 13: 272-286, 2008.
23. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006.
24. Xu Y, Li WL, Fu L, et al: Slit2/Robo1 signaling in glioma migration and invasion. Neurosci Bull 26: 474-478, 2010.
25. Mertsch S, Schmitz N, Jeibmann A, et al: Slit2 involvement in glioma cell migration is mediated by Robo1 receptor. J Neurooncol 87: 1-7, 2008.
26. Bader AG, Brown D and Winkler M: The promise of microRNA replacement therapy. Cancer Res 70: 7027-7030, 2010.
27. Roth P, Wischhusen J, Happold C, et al: A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem 118: 449-457, 2011.